Key | % Net Assets |
---|---|
AstraZeneca | 5.3% |
GlaxoSmithKline | 4.6% |
Vodafone Group | 4.5% |
Legal & General Group | 4.2% |
Other | 81.4% |
Name | % Net Assets |
---|---|
AstraZeneca | 5.3% |
GlaxoSmithKline | 4.6% |
Vodafone Group | 4.5% |
Legal & General Group | 4.2% |
Logica | 4.2% |
Resolution | 3.0% |
Royal Bank of Scotland | 2.9% |
Old Mutual | 2.8% |
Henry Boot | 2.8% |
Taylor Wimpey | 2.7% |
No asset data available.
Date | 29-Apr-2024 |
---|---|
NAV | 14,000.00p |
Currency | GBP |
Change | 70.00p |
% | 0.50% |
YTD change | 170.00p |
YTD % | 1.23% |
Fund Inception | 05/05/1970 |
---|---|
Fund Manager | Kevin Murphy / Nick Kirrage |
TER | 1.52 (15-Jul-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.19 |
You are here: research